Fitch analysts said Ms. Barnett-Sarpalius and the rest of the CHE management team continue “to execute on its strategic plan in each of its key markets and is expected to improve financial performance” in the years ahead.
CHE has a high percentage of both Medicaid and Medicare patients, at 17.4 percent and 48.2 percent of gross revenues in 2011, respectively. However, Ms. Barnett-Sarpalius and CHE have still been able to post year-over-year improvement in both operating margin and operating EBITDA margin in each of the past three fiscal years. At the end of the most recent quarter ended March 31, 2012, CHE also had 163.1 days cash on hand and 17.2 times cushion ratio, which compares favorably to other Fitch hospitals rated similarly to CHE.
Previously, Ms. Barnett-Sarpalius was also CHE’s vice president and chief accounting officer before being promoted to CFO in 2010. She also served as director of finance and corporate controller at CHRISTUS Health in Irving, Texas.
More Articles on Hospital CFO Profiles:
CFO Tom Thompson: Finding Fiscal Stability in Rural West Virginia
CFO David Kirshner: Instilling High-Quality Credit at Boston Children’s Hospital
CFO Vince Schmitz: Stalwart of the West Coast Healthcare Sector
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
